logo

Theravance Biopharma Inc. (TBPH)



Trade TBPH now with
  Date
  Headline
2/7/2018 7:34:03 AM Theravance Biopharma Enters Global Collaboration With Janssen For TD-1473 In Inflammatory Intestinal Diseases
1/29/2018 8:33:06 AM Theravance, Mylan Announce FDA Acceptance Of NDA For Revefenacin In Adults With Chronic Obstructive Pulmonary Disease
11/13/2017 9:29:40 AM Theravance And Mylan Submit NDA To FDA For Revefenacin (TD-4208) In Adults With Chronic Obstructive Pulmonary Disease
11/1/2017 8:37:21 AM Theravance Biopharma And Mylan Report Additional Positive Phase 3 Data For Revefenacin (TD-4208)
11/1/2017 6:06:57 AM Theravance Biopharma Announces Opening Of Company's New Corporate Office In Dublin, Ireland
10/31/2017 8:42:00 AM Theravance Presents Positive Preliminary New Data From Telavancin Observational Use Registry Study
10/9/2017 8:32:26 AM Theravance Biopharma Reports Positive New Data From Multiple Studies Of VIBATIV
9/18/2017 8:32:36 AM Theravance Highlights GSK And Innoviva's Receipt Of Positive Opinion From CHMP In Europe For Trelegy Ellipta
8/2/2017 7:09:30 AM Theravance Reports Positive Top-Line Results From Phase 2b Study Of Velusetrag (TD-5108) In Patients With Gastroparesis
7/19/2017 4:25:44 PM Theravance, Mylan Report Positive Results From 12-Month Phase 3 Safety Study Of Revefenacin (TD-4208) In COPD Patients
5/23/2017 9:16:17 AM Theravance Biopharma And Mylan Report Additional Phase 3 Data For Revefenacin In Several Presentations